Filter
2716
Filtered Results: 2716
Text search:
Global
Drug
Facility
Featured
Recommendations
263
New Publications
860
Language
Document type
No document type
1644
Guidelines
375
Studies & Reports
373
Manuals
125
Strategic & Response Plan
107
Training Material
37
Fact sheets
30
Situation Updates
13
Resource Platforms
7
Infographics
3
Brochures
1
App
1
Countries / Regions
India
136
Kenya
99
Global
87
Ethiopia
83
Nigeria
76
South Africa
74
Uganda
71
Tanzania
67
Malawi
59
Nepal
58
Liberia
55
Zambia
52
Ghana
50
Sierra Leone
50
Bangladesh
42
Namibia
41
Western and Central Europe
40
Myanmar / Burma
39
Rwanda
37
Africa
30
Eastern Europe
28
Ukraine
27
Zimbabwe
26
Lesotho
25
Asia
25
Cambodia
24
Latin America and the Carribbean
24
Philippines
23
South–East Asia Region
18
Syria
16
Mozambique
16
Senegal
15
Burkina Faso
15
Congo, Democratic Republic of
15
Botswana
15
Indonesia
15
Russia
12
Cameroon
11
East and Southern Africa
9
Eswatini/ Swaziland
9
South Sudan
8
Pakistan
8
Tajikistan
6
Benin
6
Haiti
6
West and Central Africa
6
Middle East and North Africa
6
Colombia
5
Laos
5
Guinea
5
Venezuela
5
Western Pacific Region
5
Eastern Europe and Central Asia
5
Sudan
5
Yemen
5
Thailand
4
Mexico
4
El Salvador
4
China
4
Afghanistan
4
Germany
4
Vietnam
4
Sri Lanka
4
Timor Leste/ East Timor
3
Peru
3
Brazil
3
Moldova
3
Palestine
3
Georgia
3
Central African Republic
3
Libya
3
Somalia
3
North Macedonia
2
Chile
2
Iran
2
Albania
2
Armenia
2
USA
2
Jordan
2
Gabon
2
France
2
Côte d’Ivoire / Ivory Coast
2
Lebanon
2
Papua New Guinea
2
Mali
2
Bhutan
2
Iraq
2
Madagascar
2
Serbia
1
Turkey
1
Gambia
1
Kazakhstan
1
Kyrgyzstan
1
Congo-Brazzaville
1
Niger
1
Uzbekistan
1
Morocco
1
Mongolia
1
Qatar
1
Bulgaria
1
Lithuania
1
Ireland
1
Saudi Arabia
1
Turkmenistan
1
Denmark
1
Maldives
1
Tunisia
1
United Kingdom
1
Portugal
1
Spain
1
Argentina
1
Romania
1
Greece
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
1229
Clinical Guidelines
233
Public Health
123
Women & Child Health
111
Key Resources
107
Capacity Building
46
Pharmacy & Technologies
36
Toolboxes
TB
345
HIV
299
AMR
158
COVID-19
124
Mental Health
96
Pharmacy
74
NTDs
74
Caregiver
57
Rapid Response
54
Malaria
51
NCDs
40
Conflict
35
Ebola & Marburg
34
Planetary Health
29
Refugee
27
Health Financing Toolbox
24
Global Health Education
23
Disability
21
Polio
15
Cholera
10
Natural Hazards
9
Specific Hazards
6
Zika
4
Social Ethics
2
HIV infection, due to the immunosuppressant that leads, nowadays constitutes an aggravating factor of endemic tuberculosis. Tuberculosis remains a huge burden to human health, even in the early 21st century. The situation is deteriorating in many countries, particularly because of the synergy with t...
Suicides take a high toll. Over 800 000 people die by suicide every year and it is the second leading cause of
death in 15-29-year-olds. Most suicides occur in low- and middle-income countries where resources
and services, if they do exist, are often scarce and limited for early identification, tr...
he National Department of Health (NDOH) presents this Malaria Elimination Strategic
Plan 2019-2023 for the Republic of South Africa. The strategy comes at an important time
as the Southern African Development Community (SADC) heads of state have recently
renewed the commitment to eliminate malari...
The Malaria Ministerial Conference, co-hosted by WHO and the Government of Cameroon on 6 March 2024, brought together more than 400 stakeholders, including Ministers of Health and senior representatives from the African countries hardest hit by malaria, global health leaders, scientists, civil socie...
The National Strategic Plan for Malaria Elimination 2021–2025 outlines Bangladesh’s roadmap to achieve zero indigenous malaria cases by 2030, with an interim goal to reduce transmission to near-zero levels by 2025. The strategy builds upon earlier successes in malaria control and shifts focus to...
The Rwanda Malaria Strategic Plan 2020–2024 outlines Rwanda’s national strategy to reduce malaria morbidity and mortality by at least 50% compared to 2019 levels. The vision is a malaria-free Rwanda contributing to socioeconomic development.
The plan includes strengthening prevention through lo...
BMC Infectious Diseases volume 23, Article number: 342 (2023).
Tuberculosis (TB) is among the leading causes of death globally. The disease has a huge burden in Namibia, with a case notification rate of at least 442 per 100,000. To date, Namibia is among the countries with the highest global TB bur...
In 2014, GHS/NACP, with support from UNICEF and other partners, conducted a situation analysis on paediatric HIV care and treatment in Ghana. The purpose of this analysis was to identify the gaps within the current delivery of paediatric HIV care and support system and develop a road map for effecti...
The NDMS&IP focuses on mainstreaming disability to promote equitable access to services in the six thematic areas of health, education, livelihoods, empowerment, and social inclusion and cross-cutting issues.
The first part of the NDMS&IP outlines incongruences between national and sectoral policie...
Bioethics - Medical, Ethical and Legal Perspectives
There’s evidence that implementing the four medical ethics principles may be challenging especially in low income country contexts with extreme resource scarcity and limited capacity to facilitate deliberations on the different ethical dilemmas....
Cardiovascular disease is a major cause of disability and premature death throughout the world, and contributes substantially to the escalating costs of health care. The underlying pathology is atherosclerosis, which develops over many years and is usually advanced by the time symptoms occur, genera...
Some of the key findings of the report include:
Almost 80% of the general public are concerned about developing dementia at some point and 1 in 4 people think that there is nothing we can do to prevent dementia
35% of carers across the world said that they have hidden the diagnosis of de...
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good manufacturing practices (GMP) is one of the most important tools for this measure.
WHO’s Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritize critical health products that should be widely available and affordable throughout health systems. The updated Essential Medicines List adds 23 medicines for children.
Why bold action against inequalities is needed to en AIDS, stop COVID-19 and prepare for future pandemics
